MAL À vista: consequências associadas AO USO DO tabaco para a saúde DOS olhos
Abstract
Introduction: Smoking is widely recognized as a risk factor for several eye diseases, including age-related macular degeneration (AMD), cataract, glaucoma, and dry eye syndrome. Toxic substances present in cigarettes, such as nicotine and carbon monoxide, directly affect ocular tissues, resulting in oxidative and ischemic damage. This study reviews the literature on the effects of smoking on ocular health, highlighting the main mechanisms involved and the implications for public health. Methodology: A descriptive and analytical literature review was carried out. Scientific articles published between 2000 and 2024 in the PubMed, SciELO, and BVS databases were included. The keywords used were "smoking", "eye health", "cataract", "AMD", "glaucoma", and "dry eye syndrome". Studies that addressed the impact of active and passive smoking on ocular health were selected. Furthermore, clinical trials, systematic reviews and meta-analyses were considered. Discussion and Results: The reviewed studies indicate that smoking significantly increases the risk of eye diseases. Smokers are two to four times more likely to develop AMD compared to non-smokers, in addition to a threefold increased risk of cataracts. Smoking also worsens glaucoma, contributing to progressive vision loss due to increased intraocular pressure. Dry eye syndrome has been identified as one of the most common conditions associated with smoking, with reduced tear quality and quantity. Secondhand smoke has also been…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.